# AI Therapeutics

**Canonical:** https://apis.io/providers/ai-therapeutics/  
**Website:** https://orphai-therapeutics.com/  
**APIs profiled:** 0

AI Therapeutics (now Orphai Therapeutics) is a clinical-stage biopharmaceutical company founded in Guilford, Connecticut by Jonathan Rothberg as LAM Therapeutics, renamed AI Therapeutics, and renamed again to OrphAI Therapeutics in September 2023. It built an internal deep-learning platform that synthesized public and proprietary drug and disease data to match existing chemical entities to new indications, and used it to advance a rare-disease and pulmonary pipeline — LAM-001, an inhaled formulation of sirolimus (rapamycin) targeting mTOR-driven pulmonary disease, plus the earlier PIKfyve inhibitor programs LAM-002 and LAM-003. Quince Therapeutics (Nasdaq: QNCX) acquired Orphai in May 2026 and now runs it as a subsidiary. The AI platform is an internal drug-discovery tool, not a product: the company operates no developer program, publishes no API, SDK or machine-readable contract, and its public web presence is a single-page corporate site.

## Kin Score — 4.0 / 100 (minimal)

Scored 2026-09-14 under rubric 0.22.0.

| Facet | Score |
|---|---|
| Discoverability | 50.0 |
| Contract Quality | 0.0 |
| Contract Governance | 0.0 |
| Operational Transparency | 5.3 |
| Developer Ergonomics | 0.0 |
| Access Clarity | 0.0 |

Regulatory layer — **Health**: 7.5 (matched via tags).

## Agent readiness — 2.9 (human-only)

| Dimension | Value |
|---|---|
| Spec Presence | no |
| Agentic Access | no |
| Reversibility Documented | no |
| MCP Server | no |
| Auth Clarity | no |
| Idempotency | no |
| Error Semantics | no |
| OpenAPI Examples | no |
| Rate Limit Signal | no |
| Event Surface Described | no |
| Agent Skills | no |
| Well Known Catalog | yes |
| Consent Identity | no |
| Agent Card | no |
| Dry Run Mode | no |
| Delegated Identity | no |
| Protected Resource Metadata | no |
| Dynamic Client Registration | no |
| Agentic Commerce | no |

## Security (1)

- **Ai Therapeutics Domain Security** — TLSv1.3 · HSTS · DMARC

## Tags

Company, Biotechnology, Pharmaceuticals, Life Sciences, Drug Discovery, Artificial Intelligence, Clinical Trials, Rare Disease

---

Profiled by [API Evangelist](https://apievangelist.com) and published on [APIs.io](https://apis.io/providers/ai-therapeutics/). Scores are computed from the provider's own public artifacts under a published rubric.